Related Experiment Video

Updated: Apr 7, 2026

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

1.6K

Targeting female hormone receptors as cervical cancer therapy

Sang-Hyuk Chung1

  • 1Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, TX 77204, USA.

Trends in Endocrinology and Metabolism: TEM
|July 13, 2015
PubMed

Insights

Preventive cervical cancer methods work, but advanced treatments fail. New research reveals opposing roles of estrogen receptor alpha (ERα) and progesterone receptor (PR) for potential new therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gynecology

Background:

  • Preventive measures for cervical cancer are effective.
  • Current therapies for advanced cervical cancer lack efficacy.
  • Estrogen receptor alpha (ERα) and progesterone receptor (PR) play complex roles in cervical cancer.

Purpose of the Study:

  • To address the ineffectiveness of current advanced cervical cancer treatments.
  • To provide new molecular insights into the roles of ERα and PR.
  • To explore potential therapeutic strategies targeting ERα and PR in cervical cancer.

Main Methods:

  • Critically evaluate existing studies on cervical cancer therapies.
  • Investigate the molecular mechanisms of ERα and PR signaling.
  • Analyze experimental evidence for therapeutic potential.

Main Results:

  • Identified weaknesses in previous research methodologies.
  • Elucidated the opposing functions of ERα and PR in cervical cancer.
  • Provided evidence for the potential of targeting these receptors.

Conclusions:

  • New molecular insights into ERα and PR offer therapeutic avenues.
  • Targeting ERα and PR may benefit a subset of cervical cancer patients.
  • Further research is warranted to translate these findings into clinical practice.
Keywords:
cervical cancerestrogen receptor αhormonal therapyhuman papillomavirusprogesterone receptor

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K
Generation and Genetic Manipulation of Human Cervical Organoids09:41

Generation and Genetic Manipulation of Human Cervical Organoids

Published on: March 10, 2026

68

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K